+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharmaceutical Manufacturing Market by Drug Type, Dosage Form, Manufacturing Stage, Manufacturing Technology, End Use - Global Forecast to 2030- Product Image
Pharmaceutical Manufacturing Market by Drug Type, Dosage Form, Manufacturing Stage, Manufacturing Technology, End Use - Global Forecast to 2030- Product Image
Sale

Pharmaceutical Manufacturing Market by Drug Type, Dosage Form, Manufacturing Stage, Manufacturing Technology, End Use - Global Forecast to 2030

  • PDF Icon

    Report

  • 187 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5896347
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The pharmaceutical manufacturing market is navigating significant transformation, defined by dynamic technological progress, evolving regulations, and complexity across global supply chains. For senior decision-makers, achieving operational resilience and innovation is now essential for sustained leadership in this changing landscape.

Market Snapshot: Pharmaceutical Manufacturing Market

The Pharmaceutical Manufacturing Market grew from USD 672.44 billion in 2024 to USD 731.63 billion in 2025. It is expected to continue growing at a CAGR of 8.73%, reaching USD 1.11 trillion by 2030. This sustained momentum is underpinned by digital transformation, innovative production techniques, and rising demand for next-generation therapies.

Scope & Segmentation

  • Drug Types: Biosimilars, Branded Drugs, Generic Drugs
  • Dosage Forms: Capsules, Powders, Tablets, Emulsions, Solutions, Suspensions, Infusion Forms, Prefilled Syringes, Vials
  • Manufacturing Stages: API Manufacturing, Formulation Manufacturing, Packaging and Labelling
  • Manufacturing Technologies: Batch Manufacturing, Continuous Manufacturing, Single-Use Technology
  • End Use: Animal Health, Human Health
  • Geographic Coverage: Americas (United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (including United Kingdom, Germany, France), Asia-Pacific (China, India, Japan, Australia, South Korea, others)
  • Leading Companies: Pfizer Inc., Roche Holding AG, Johnson & Johnson, Merck & Co., Novartis AG, AbbVie Inc., Sanofi S.A., AstraZeneca plc, Eli Lilly and Company, Bristol-Myers Squibb Company

Key Takeaways from Emerging Trends

  • Digital transformation is streamlining quality control and introducing continuous manufacturing, which helps minimize production bottlenecks and improves product consistency.
  • Manufacturers are integrating sustainability initiatives by adopting energy-efficient technologies and green chemistry principles, reflecting stakeholder and board-level priorities.
  • Segment diversity continues to expand, with biosimilar and specialty therapies becoming more prevalent in response to patent expirations and evolving healthcare needs.
  • Single-use and modular systems enable greater production agility, allowing rapid adaptation to new therapies or shifting market demands.
  • Strong collaboration across industry, technology providers, and academia is accelerating the adoption of advanced manufacturing platforms, providing flexibility for both established firms and emerging players.

Tariff Impact on Supply Chains

Tariff adjustments implemented by the United States in 2025 have introduced new cost considerations for raw materials and components. Many manufacturers are rethinking procurement by diversifying supplier networks and considering nearshoring to buffer against trade volatility. These strategies, including temporary stockpiling and stronger partnerships with domestic sources, are designed to maintain operational continuity. At the same time, the regulatory and documentation burden has intensified, demanding more robust compliance processes and agile sourcing solutions to safeguard profitability and supply chain resilience.

Methodology & Data Sources

This report leverages a rigorous multi-source methodology. Primary insights are sourced from executive interviews within the pharmaceutical and biotech sectors, as well as discussions with authorities and supply chain experts. Secondary research draws from peer-reviewed journals, patent filings, and relevant corporate disclosures, supported by trade publications and industry association data. All qualitative and quantitative insights are vetted through multiple peer review stages to ensure robust, objective analysis for senior stakeholders.

Why This Report Matters

  • Enables executive leadership to efficiently align investment and resource allocation strategies with prioritized market drivers and operational opportunities.
  • Equips organizations with actionable intelligence to proactively address regulatory changes, technology adoption challenges, and regional growth dynamics.
  • Supports decision-makers in optimizing global manufacturing footprints by clarifying nuanced market segmentation and evolving supply chain requirements.

Conclusion

The pharmaceutical manufacturing sector stands at a turning point, requiring adaptable strategies and cross-functional leadership. Decision-makers committed to continuous process improvement and collaborative innovation will be best positioned to guide their organizations successfully through this next era of industry evolution.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Pharmaceutical Manufacturing Market, by Drug Type
8.1. Introduction
8.2. Biosimilars
8.3. Branded Drugs
8.4. Generic Drugs
9. Pharmaceutical Manufacturing Market, by Dosage Form
9.1. Introduction
9.2. Liquid Dosage Forms
9.2.1. Emulsion
9.2.2. Solution
9.2.3. Suspension
9.3. Parenteral Dosage Forms
9.3.1. Infusion Forms
9.3.2. Injectable Forms
9.3.2.1. Prefilled Syringe
9.3.2.2. Vial
9.4. Solid Dosage Forms
9.4.1. Capsule
9.4.2. Powder
9.4.3. Tablet
10. Pharmaceutical Manufacturing Market, by Manufacturing Stage
10.1. Introduction
10.2. API Manufacturing
10.3. Formulation Manufacturing
10.4. Packaging and Labelling
11. Pharmaceutical Manufacturing Market, by Manufacturing Technology
11.1. Introduction
11.2. Batch Manufacturing
11.3. Continuous Manufacturing
11.4. Single-Use Technology
12. Pharmaceutical Manufacturing Market, by End Use
12.1. Introduction
12.2. Animal Health
12.3. Human Health
13. Americas Pharmaceutical Manufacturing Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Pharmaceutical Manufacturing Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Pharmaceutical Manufacturing Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. Pfizer Inc.
16.3.2. Roche Holding AG
16.3.3. Johnson & Johnson
16.3.4. Merck & Co., Inc.
16.3.5. Novartis AG
16.3.6. AbbVie Inc.
16.3.7. Sanofi S.A.
16.3.8. AstraZeneca plc
16.3.9. Eli Lilly and Company
16.3.10. Bristol-Myers Squibb Company
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. PHARMACEUTICAL MANUFACTURING MARKET MULTI-CURRENCY
FIGURE 2. PHARMACEUTICAL MANUFACTURING MARKET MULTI-LANGUAGE
FIGURE 3. PHARMACEUTICAL MANUFACTURING MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2030 (%)
FIGURE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2024 VS 2030 (%)
FIGURE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2024 VS 2030 (%)
FIGURE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2024 VS 2030 (%)
FIGURE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. PHARMACEUTICAL MANUFACTURING MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. PHARMACEUTICAL MANUFACTURING MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. PHARMACEUTICAL MANUFACTURING MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BIOSIMILARS, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BRANDED DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY GENERIC DRUGS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY EMULSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLUTION, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SUSPENSION, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INFUSION FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PREFILLED SYRINGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY VIAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CAPSULE, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY POWDER, BY REGION, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY TABLET, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY API MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY FORMULATION MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PACKAGING AND LABELLING, BY REGION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY BATCH MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY CONTINUOUS MANUFACTURING, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SINGLE-USE TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY ANIMAL HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY HUMAN HEALTH, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 59. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 60. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 61. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 62. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 63. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 64. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 65. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 66. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. CANADA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 68. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 69. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 70. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 71. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 72. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 73. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 74. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 75. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. MEXICO PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 81. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 89. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 90. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 98. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 99. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 106. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 107. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 108. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 109. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 114. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 115. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 116. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 117. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 118. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 119. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 120. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 121. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. GERMANY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 123. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 124. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 125. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 126. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 127. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 128. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 129. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 130. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. FRANCE PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 132. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 133. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 134. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 135. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 136. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 141. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 142. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 143. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 144. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 145. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 146. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 147. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 148. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 149. ITALY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 150. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 151. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 152. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 153. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 154. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 155. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 156. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 157. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 158. SPAIN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 159. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 160. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 161. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 162. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 163. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 168. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 169. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 170. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 171. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 172. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 177. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 178. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 179. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 180. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 181. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 186. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 187. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 188. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 189. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 190. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 191. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 192. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 193. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 194. DENMARK PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 195. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 196. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 197. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 198. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 199. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 204. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 205. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 206. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 207. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 208. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 209. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 210. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 211. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 212. QATAR PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 213. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 214. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 215. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 216. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 217. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 218. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 219. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 220. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 221. FINLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 222. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 223. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 224. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 225. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 226. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 231. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 232. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 233. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 234. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 235. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 240. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 241. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 242. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 243. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 244. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 245. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 246. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 247. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 248. EGYPT PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 249. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 250. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 251. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 252. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 253. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 254. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 255. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 256. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 257. TURKEY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 258. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 259. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 260. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 261. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 262. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 267. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 268. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 269. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 270. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 271. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 272. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 273. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 274. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 275. NORWAY PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 276. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 277. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 278. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 279. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 280. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 281. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 282. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 283. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 284. POLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 285. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 286. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 287. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 288. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 289. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 294. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 295. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DOSAGE FORM, 2018-2030 (USD MILLION)
TABLE 296. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY LIQUID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 297. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY PARENTERAL DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 298. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY INJECTABLE FORMS, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY SOLID DOSAGE FORMS, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING STAGE, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY MANUFACTURING TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY END USE, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 304. CHINA PHARMACEUTICAL MANUFACTURING MARKET SIZE, BY DRUG TYPE, 2018-2030 (USD MILLION)
TABLE 305. CHINA PHARMACEUTICAL MANUFACTU

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Pharmaceutical Manufacturing market report include:
  • Pfizer Inc.
  • Roche Holding AG
  • Johnson & Johnson
  • Merck & Co., Inc.
  • Novartis AG
  • AbbVie Inc.
  • Sanofi S.A.
  • AstraZeneca plc
  • Eli Lilly and Company
  • Bristol-Myers Squibb Company

Table Information

Report AttributeDetails
No. of Pages187
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 731.63 Billion
Forecasted Market Value ( USD ) by 2030 $ 1110 Billion
Compound Annual Growth Rate8.7%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Pharmaceutical Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029) - Product Image

Pharmaceutical Manufacturing - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2024 - 2029)

  • Report
  • 130 Pages
  • Global
From
Pharmaceutical Contract Development & Manufacturing Market by Service Type, Technology, Development Stage, End Use, Customer Type - Global Forecast to 2030 - Product Image

Pharmaceutical Contract Development & Manufacturing Market by Service Type, Technology, Development Stage, End Use, Customer Type - Global Forecast to 2030

  • Report
  • 196 Pages
  • Global
From
Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Customer Type, Therapeutic Area, Contract Type, Production Scale, Process Type - Global Forecast to 2030 - Product Image

Pharmaceutical Contract Manufacturing Market by Service Type, Molecule Type, Dosage Form, Customer Type, Therapeutic Area, Contract Type, Production Scale, Process Type - Global Forecast to 2030

  • Report
  • 188 Pages
  • Global
From
High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030 - Product Image

High Potency API Contract Manufacturing Market Size, Share & Trends Analysis Report by Product (Innovative, Generic), Dosage Form (Injectable, Creams), Application, Synthesis, Region, and Segment Forecasts, 2025-2030

  • Report
  • 130 Pages
  • Global
From
Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024 - 2030 - Product Image

Semi-solid Dosage Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Topical, Transdermal, Oral), By Product (Creams, Gels), By End Use, By Company Size, By Region, And Segment Forecasts, 2024 - 2030

  • Report
  • 150 Pages
  • Global
From

About the Pharmaceutical Manufacturing Market

The Pharmaceutical Manufacturing market is composed of companies that produce drugs and other pharmaceutical products. These products are used to treat and prevent diseases, as well as to improve the quality of life. Pharmaceutical manufacturers are responsible for the research, development, production, and distribution of these products. They must adhere to strict regulations and standards to ensure the safety and efficacy of their products. The Pharmaceutical Manufacturing market is highly competitive, with many large companies vying for market share. Some of the major players in the market include Pfizer, Merck, Johnson & Johnson, Novartis, and GlaxoSmithKline. These companies are involved in the research, development, production, and distribution of pharmaceutical products. They are also involved in the marketing and promotion of their products. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.